{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:46:12Z","timestamp":1789076772360,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ando.2015.12.001","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T09:16:35Z","timestamp":1454058995000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance"],"prefix":"10.1016","volume":"77","author":[{"given":"Anne Laure","family":"Bourgeois","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Auriche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5660-9224","authenticated-orcid":false,"given":"Aurore","family":"Palmaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2015.12.001_bib0195","series-title":"Troubles de l\u2019identit\u00e9 sexuelle. CIM 10","first-page":"390","author":"OMS","year":"1993"},{"key":"10.1016\/j.ando.2015.12.001_bib0200","series-title":"Situation actuelle et perspectives d\u2019\u00e9volution de la prise en charge m\u00e9dicale du transsexualisme en France","author":"HAS","year":"2009"},{"key":"10.1016\/j.ando.2015.12.001_bib0205","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.purol.2013.01.021","article-title":"Le transsexualisme","volume":"23","author":"Morel Journel","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.ando.2015.12.001_bib0210","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0447.1996.tb10638.x","article-title":"Prevalence, incidence and sex ratio of transsexualism","volume":"93","author":"Land\u00e9n","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.ando.2015.12.001_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eurpsy.2006.10.002","article-title":"Prevalence and demography of transsexualism in Belgium","volume":"22","author":"De Cuypere","year":"2007","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.ando.2015.12.001_bib0220","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0025-7753(00)71691-5","article-title":"Tratamiento de reasignacion de sexo en pacientes transexuales","volume":"115","author":"Pav\u00f3n de Paz","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.ando.2015.12.001_bib0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.sexol.2008.06.003","article-title":"Trouble de l\u2019identit\u00e9 de genre\u00a0: quel est le r\u00f4le du psychiatre\u00a0?","volume":"17","author":"Gorin-Lazard","year":"2008","journal-title":"Sexologies"},{"key":"10.1016\/j.ando.2015.12.001_bib0230","series-title":"Standards of care for gender identity disorders, sixth version","author":"Harry Benjamin International Gender Dysphoria Association","year":"2001"},{"key":"10.1016\/j.ando.2015.12.001_bib0235","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ando.2007.06.017","article-title":"Le traitement hormonal des patients transsexuels et ses cons\u00e9quences m\u00e9taboliques","volume":"68","author":"Corman","year":"2007","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0240","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/0004-2730000003091","article-title":"Clinical management of transsexual subjects","volume":"58","author":"Frada Costa","year":"2014","journal-title":"Arq Bras Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.12.001_bib0245","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in heathly postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2015.12.001_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s40264-014-0149-8","article-title":"Thromboembolic events in women exposed to hormonal contraception or cyproterone acetate in 2012: a cross-sectional observational study in 30 French public hospitals","volume":"37","author":"Gourbil","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.ando.2015.12.001_bib0255","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1210\/jc.2014-2262","article-title":"Clinical review: the benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","author":"Elraiyah","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.12.001_bib0260","first-page":"1","article-title":"Circulating androgens are associated with mood disturbances in young postmenopausal women","volume":"7","author":"Lambrinoudaki","year":"2015","journal-title":"Climateric"},{"key":"10.1016\/j.ando.2015.12.001_bib0265","first-page":"347","article-title":"Le transsexuel\u00a0: quel devenir\u00a0?","volume":"159","author":"Michel","year":"2001","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.ando.2015.12.001_bib0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"van Kesteren","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0275","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.ando.2015.12.001_bib0280","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-13-0493","article-title":"Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study","volume":"169","author":"Wierckx","year":"2013","journal-title":"Euro J Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0285","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.ando.2015.12.001_bib0290","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1530\/EJE-14-0011","article-title":"Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern","volume":"170","author":"Gooren","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0295","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0300","first-page":"583","article-title":"Prolactin levels and pituitary enlargement in hormone-treated male-to-female transsexuals","volume":"28","author":"Asscheman","year":"1988","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0305","first-page":"84","article-title":"Morbilidad en pacientes transsexuales con autoratamiento hormonal para camblio de sexo","volume":"113","author":"Becerra Fernandez","year":"1999","journal-title":"Med Clin"},{"key":"10.1016\/j.ando.2015.12.001_bib0310","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1023\/A:1018704630036","article-title":"A follow-up study for estimating the effectiveness of a cross-gender hormone substitution therapy on transsexual patients","volume":"27","author":"Schlatterer","year":"1998","journal-title":"Arch Sex Behav"},{"key":"10.1016\/j.ando.2015.12.001_bib0315","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1210\/jcem-66-2-444","article-title":"Estrogen-induced prolactinoma in a man","volume":"66","author":"Gooren","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2015.12.001_bib0320","first-page":"562","article-title":"Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study","volume":"118","author":"Kovacs","year":"1994","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ando.2015.12.001_bib0325","first-page":"353","article-title":"Estrogen-induced severe acute pancreatitis in a male","volume":"5","author":"Perego","year":"2004","journal-title":"JOP"},{"key":"10.1016\/j.ando.2015.12.001_bib0330","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jbmr.5650040503","article-title":"The effect of crossgender hormonal treatment on bone metabolism in male-to-female transsexuals","volume":"4","author":"Lips","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2015.12.001_bib0335","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-0029-1211999","article-title":"Transsexualism and osteoporosis","volume":"106","author":"Schlatterer","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.ando.2015.12.001_bib0340","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-004-1754-7","article-title":"Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study","volume":"16","author":"Ruetsche","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2015.12.001_bib0345","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatement with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2015.12.001_bib0350","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1046\/j.1464-410x.1998.00582.x","article-title":"Metastatic prostatic carcinoma in a male-to-female transsexual","volume":"81","author":"van Haarst","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.ando.2015.12.001_bib0355","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1001\/jama.296.19.2316","article-title":"Prostate cancer in a transgender woman 41 years after initiation of feminization","volume":"296","author":"Miksad","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ando.2015.12.001_bib0360","first-page":"69","article-title":"Breast fibroadenoma in a male-to-female transsexual patient after hormonal treatment","volume":"168","author":"Lemmo","year":"2002","journal-title":"Eur J Surg"},{"key":"10.1016\/j.ando.2015.12.001_bib0365","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1369\/jhc.6A6928.2006","article-title":"Effects of long-term androgen administration on breast tissue of female-to-male transsexuals","volume":"54","author":"Slagter","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ando.2015.12.001_bib0370","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/and.12399","article-title":"Five new cases of breast cancer in transsexual persons","volume":"47","author":"Gooren","year":"2015","journal-title":"Andrologia"},{"key":"10.1016\/j.ando.2015.12.001_bib0375","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1111\/jsm.12563","article-title":"Conjectures concerning cross-sex hormon treatment of aging transsexual persons","volume":"11","author":"Gooren","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/j.ando.2015.12.001_bib0380","series-title":"Enqu\u00eate sur le v\u00e9cu des jeunes populations trans en France","author":"La Commission Trans d\u2019HES et l\u2019\u00e9quipe projet Trans du MAG","year":"2009"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615011324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426615011324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:48:19Z","timestamp":1757717299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426615011324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0003426615011324"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2015.12.001","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}